Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery (PASS)
Primary Purpose
Shoulder Pain
Status
Completed
Phase
Phase 4
Locations
Canada
Study Type
Interventional
Intervention
Suprascapular & axillary blocks
Interscalene block
Sponsored by
About this trial
This is an interventional treatment trial for Shoulder Pain
Eligibility Criteria
Inclusion Criteria:
- Consented, English-speaking, adult patients (age > 18)
- American Society of Anesthesiologists (ASA) classification I-III
- BMI ≤ 30 kg/m2
Exclusion Criteria:
- Total shoulder arthroplasty or clavicular surgery (ISB does not provide sufficient pain relief)
- Known broncho-pulmonary or phrenic pathology compromising respiratory function
- Contra-indication to nerve blocks e.g., infection, bleeding diathesis, allergy to local anesthetics
- Existing chronic pain disorders or history of use of ≥ 30mg oxycodone or equivalent per day
- Pre-existing neurological deficits or peripheral neuropathy involving the operative upper extremity
- Contraindication to any component of multi-modal analgesia (acetaminophen, non-steroidal anti-inflammatory medications, oral opioid analgesics)
- Pregnancy or any significant psychiatric conditions that may affect patient assessment
Sites / Locations
- Women's College Hospital
- Toronto Western Hopspital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Suprascapular & axillary blocks
Interscalene block
Arm Description
Suprascapular and axillary blocks.
Interscalene block.
Outcomes
Primary Outcome Measures
Postoperative pain severity
Numeric rating scale (NRS) scores will be evaluated by blinded study coordinators who are not involved in patient care.
Secondary Outcome Measures
Rest pain at additional time points
Quality of Recovery (QoR)
The impact of surgical and anesthetic interventions on perioperative quality of life and ability to resume routine life activities will be assessed using the Quality of Recovery (QoR) tool. The QoR-15 scale is a patient-based outcome measure in the form of a 15-item validated questionnaire.
Full Information
NCT ID
NCT02517437
First Posted
July 20, 2015
Last Updated
May 29, 2018
Sponsor
University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT02517437
Brief Title
Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery
Acronym
PASS
Official Title
Novel Combination of Suprascapular & Axillary Nerve Blocks Versus Conventional Interscalene Brachial Plexus Block for Pain Relief Following Shoulder Surgery: A Multi-centre Randomized, Patient & Assessor Blinded, Non-inferiority Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
August 2015 (undefined)
Primary Completion Date
January 2018 (Actual)
Study Completion Date
January 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine whether the combination of suprascapular and axillary nerve blocks is non-inferior to the conventional interscalene block (ISB) in providing pain relief during the first postoperative day to adult healthy patients (age > 18) undergoing ambulatory shoulder surgery.
Detailed Description
Study Hypothesis:The pain relief provided by a combination of suprascapular and axillary nerve blocks is non-inferior to that produced by the conventional interscalene block during the first 24hours postoperatively in adult patients undergoing ambulatory shoulder surgery.
Intervention and Comparator: Consented patients will be randomized to receive either pre-operative ISB (plus sham SAB with subcutaneous saline), or SAB (plus sham ISB). Both groups will receive general anesthesia for surgery.
Primary Aim: To demonstrate non-inferiority of pain relief produced by the combination treatment compared to the conventional treatment by comparing the area under the curve of the postoperative pain scores plot over time during the first 24 hours postoperatively.
Secondary Aims: There are four secondary aims, covering efficacy (analgesia) and safety: rest pain, quality of recovery, safety, other pain relief indicators.
Design There will be a multi-centre, prospective, randomized, patient and assessor blinded, two-arm, parallel-group, 1:1 allocation ratio, placebo-controlled, non-inferiority clinical trial comparing the effect of SAB treatment to conventional ISB treatment on pain relief during the first postoperative 24 hours in patients undergoing ambulatory shoulder surgery under general anesthesia.
Methods Study participants
The target population will be adult patients (age > 18) presenting for outpatient (same day surgery) unilateral arthroscopic or open shoulder surgery. Eligible surgical procedures are:
Shoulder arthroscopy
Shoulder instability procedures
Superior labrum anterior posterior repair (SLAP)
Rotator cuff repair
Bankart repair
Acromioplasty
Study centres The trial will be conducted at the two academic medical centres in Toronto where ambulatory shoulder surgery is routinely performed: Toronto Western Hospital (TWH),and Women's College Hospital (WCH).
Preoperative management Unless allergic, all patients will receive acetaminophen 1 gr and celecoxib 400 mg orally with sips of water one hour prior to surgery. All blocks will be performed in the block room one hour before surgery.
Suprascapular and axillary nerve blocks (SAB group) Patients allocated to the suprascapular and axillary nerve block combination (SAB group) will receive these blocks in the sitting position. The shoulder will be in the neutral position but rotated 45 degrees inward and the elbow flexed at 90 degrees while the hand rests on the knees. The suprascapular nerve will be blocked as it branches from the superior trunk.78After sterile skin preparation with chlorhexidine, a linear array transducer (6-13 MHz, Sonosite M-Turbo) probe protected by a 3M Tegaderm® dressing or a sterile sheath is placed in the transverse plane to visualize C5 and C6 roots in the interscalene groove. These roots are then traced distally to where they coalesce to form the superior trunk. The suprascapular nerve is then identified and as it emerges from the superior trunk, under the deep cervical fascia and superficial to the middle scalene muscle. After infiltration with 1 mL of 1% lidocaine, a 5 cm 22 G insulated needle (B. Braun Medical Inc., Bethlehem, PA, USA) is inserted in line with the probe in a lateral-to-medial orientation towards the nerve. Local anesthetics (20 mL of 0.5% ropivacaine) will then be injected in 5 mL aliquots after negative aspiration for blood to achieve circumferential spread around the nerve.
The axillary nerve block will be performed next in the posterior aspect of the operative arm. The US transducer is placed in the longitudinal plane, parallel to the long axis of the humerus shaft and approximately 2cm below the postero-lateral part of the acromion on the posterior aspect of the arm. (Figure 1) The neurovascular bundle encompassing the humeral artery, posterior circumflex artery, and axillary nerve is visualized in the lateral edge of the quadrangular space, deep to the deltoid muscle, inferior to the teres minor muscle, and superior to the triceps tendon. After infiltration with 1 mL of 1% lidocaine, the 22G needle is inserted in line with the probe in a caudad orientation towards the bundle. Local anesthetics (20 mL of 0.5% ropivacaine) will then be injected in 5 mL aliquots after negative aspiration to achieve circumferential spread around the bundle.
Finally, to maintain patient blinding, sham ISB block will be performed in the semi-sitting position using a 25G needle to inject 1 mL of lidocaine 1% subcutaneously.
Interscalene block (ISB group) Local anesthetic solution (20 mL of 0.5% ropivacaine) will be injected in 5 mL aliquots after negative aspiration for blood to achieve spread posterior to or between the C5 and C6 nerve roots. Subsequently, patients will receive sham SAB performed in the sitting position using a 25G needle to inject 1 mL of lidocaine 1% subcutaneously.
Block assessment Assessment of sensory block onset to confirm block success is done by the research assistant doing the blocks every 5 minutes, for 30 minutes, with a blunt 22G needle applied to skin, by comparing to the contralateral upper extremity.
General anesthesia All patients will receive a standardized general anesthetic.
Postoperative management Discharged patients will receive a prescription for Tylenol #3® as needed, or Percocet® if intolerant to codeine.
Two-week follow-up A study follow-up phone call will be arranged to specifically assess any potential block-related neurologic symptoms such as pain, paresthesia, dysesthesia, sensory loss, motor power weakness. Patients found to have such symptoms will be offered a referral to the chronic pain clinic at TWH for assessment and management.
Data collection The study coordinators of the participating sites will use a paper-based case report form (CRF) prepared by the principal investigator for documentation of outcome results. Subject confidentiality will be maintained by using a study ID (not related to name, or date of birth) on all CRFs.
Sample Size Investigators aim to enroll a total of 65 patients per group, or a total of 130 patients. Based on the annual number of shoulder surgeries performed at each centre, the researchers plan to recruit 45 patients at TWH, and another 85 patients at WCH.
Source Data Verification: Patient Electronic Record
Quality Assurance & Data Checks: N/A
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Shoulder Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
130 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Suprascapular & axillary blocks
Arm Type
Active Comparator
Arm Description
Suprascapular and axillary blocks.
Arm Title
Interscalene block
Arm Type
Active Comparator
Arm Description
Interscalene block.
Intervention Type
Drug
Intervention Name(s)
Suprascapular & axillary blocks
Other Intervention Name(s)
Suprascapular and axillary blocks
Intervention Description
After infiltration with 1 mL of 1% lidocaine, local anesthetics (20 mL of 0.5% ropivacaine) will then be injected in 5 mL aliquots to achieve circumferential spread around the nerve.The axillary nerve block will be performed next in the posterior aspect of the operative arm. The neurovascular bundle encompassing the humeral artery, posterior circumflex artery, and axillary nerve is visualized in the lateral edge of the quadrangular space, deep to the deltoid muscle, inferior to the teres minor muscle, and superior to the triceps tendon. After infiltration with 1 mL of 1% lidocaine, local anesthetics (20 mL of 0.5% ropivacaine) will then be injected in 5 mL aliquots after negative aspiration to achieve circumferential spread around the bundle.
Intervention Type
Drug
Intervention Name(s)
Interscalene block
Intervention Description
After sterile skin preparation with chlorhexidine and infiltration with 1 mL of 1% lidocaine, a 5 cm 22 G insulated needle is then inserted and local anesthetic solution (20 mL of 0.5% ropivacaine) will be injected in 5 mL aliquots after negative aspiration for blood to achieve spread posterior to or between the C5 and C6 nerve roots.
Primary Outcome Measure Information:
Title
Postoperative pain severity
Description
Numeric rating scale (NRS) scores will be evaluated by blinded study coordinators who are not involved in patient care.
Time Frame
1st post-operative 24 hours
Secondary Outcome Measure Information:
Title
Rest pain at additional time points
Time Frame
0, 6, 12, 18, and 24 hours postoperatively
Title
Quality of Recovery (QoR)
Description
The impact of surgical and anesthetic interventions on perioperative quality of life and ability to resume routine life activities will be assessed using the Quality of Recovery (QoR) tool. The QoR-15 scale is a patient-based outcome measure in the form of a 15-item validated questionnaire.
Time Frame
24 hours
Other Pre-specified Outcome Measures:
Title
Hemodynamic side effect
Description
Hemodynamic side effects, defined as occurrence of bradycardia or hypo-tension.
Time Frame
24 hours
Title
Block success
Description
Block success is defined as complete sensory block over the deltoid.
Time Frame
24 hours
Title
Procedural complications
Description
Procedural complications are defined as occurrence of intravascular injection, local anesthetic systemic toxicity, hematoma, pneumothorax, epidural spread, and Horner's syndrome
Time Frame
during or just after block.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Consented, English-speaking, adult patients (age > 18)
American Society of Anesthesiologists (ASA) classification I-III
BMI ≤ 30 kg/m2
Exclusion Criteria:
Total shoulder arthroplasty or clavicular surgery (ISB does not provide sufficient pain relief)
Known broncho-pulmonary or phrenic pathology compromising respiratory function
Contra-indication to nerve blocks e.g., infection, bleeding diathesis, allergy to local anesthetics
Existing chronic pain disorders or history of use of ≥ 30mg oxycodone or equivalent per day
Pre-existing neurological deficits or peripheral neuropathy involving the operative upper extremity
Contraindication to any component of multi-modal analgesia (acetaminophen, non-steroidal anti-inflammatory medications, oral opioid analgesics)
Pregnancy or any significant psychiatric conditions that may affect patient assessment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Vincent Chan, MD
Organizational Affiliation
Toronto Western Hospital, University Health Network, University of Toronto
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Faraj Abdallah, MD
Organizational Affiliation
St. Michael's Hospital, University of Toronto
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Richard Brull, MD
Organizational Affiliation
Women's College Hospital, University of Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Women's College Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5S 1B2
Country
Canada
Facility Name
Toronto Western Hopspital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5T2S8
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
publication
Citations:
PubMed Identifier
23411725
Citation
Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.
Results Reference
background
PubMed Identifier
12520579
Citation
Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg. 2003 Jan;90(1):76-81. doi: 10.1002/bjs.4010.
Results Reference
background
PubMed Identifier
12915872
Citation
Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer. 2003 Aug 18;89(4):648-52. doi: 10.1038/sj.bjc.6601150.
Results Reference
background
PubMed Identifier
16203880
Citation
Lo IK, Litchfield RB, Griffin S, Faber K, Patterson SD, Kirkley A. Quality-of-life outcome following hemiarthroplasty or total shoulder arthroplasty in patients with osteoarthritis. A prospective, randomized trial. J Bone Joint Surg Am. 2005 Oct;87(10):2178-85. doi: 10.2106/JBJS.D.02198.
Results Reference
background
PubMed Identifier
17684891
Citation
Gutierrez DD, Thompson L, Kemp B, Mulroy SJ; Physical Therapy Clinical Research Network; Rehabilitation Research and Training Center on Aging-Related Changes in Impairment for Persons Living with Physical Disabilities. The relationship of shoulder pain intensity to quality of life, physical activity, and community participation in persons with paraplegia. J Spinal Cord Med. 2007;30(3):251-5. doi: 10.1080/10790268.2007.11753933.
Results Reference
background
Learn more about this trial
Suprascapular and Axillary Blocks Versus Interscalene Block for Shoulder Surgery
We'll reach out to this number within 24 hrs